It is unclear whether DPP-4 inhibitors have an impact on hospitalization,34,39,42 falls,34,42 fractures34,39,42 and delirium compared with no add-on treatment because either no study assessed these predefined outcomes or the quality of evidence was very low. This evidence concerns the gene DPP4 and delirium.